Globus Medical (GMED) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports Full Year and Fourth Quarter 2018 Results
February 21, 2019 4:16 PM ESTAUDUBON, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2018.
Fourth Quarter:
Worldwide sales increased 11.3% as reported to $195.9 millionFourth quarter net income was $36.8 million, or 18.8% of sales.Diluted earnings per share (EPS) were $0.36Non-GAAP diluted EPS were $0.43Non-GAAP adjusted EBITDA was 34.1% of salesFull Year 2018:
Worldwide sales increased 12.1% as reported to $713.0 millionNet income... More